Trial Profile
Phase II study of AZ-007 for the treatment of insomnia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2015
Price :
$35
*
At a glance
- Drugs Zaleplon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 11 Mar 2015 New trial record
- 09 Mar 2015 According to an Alexza Pharmaceuticals media release, this trial is expected to start in 2015.